Journal List > Korean J Gastroenterol > v.66(4) > 1007428

Jung and Park: Timing of Cholecystectomy after Percutaneous Cholecystostomy for Acute Cholecystitis

Abstract

Background/Aims

Laparoscopic cholecystectomy is the standard treatment for acute cholecystitis. Percutaneous cholecystostomy is an alternative treatment to resolve acute inflammation in patients with severe comorbidities. The purpose of this study is to determine the optimal timing of laparoscopic cholecystectomy after percutaneous cholecystostomy for the patients with acute cholecystitis.

Methods

This retrospective study was conducted in patients who underwent cholecystectomy after percutaneous cholecystostomy from January 2010 through November 2014. Seventy-four patients were included in this study. The patients were divided into two groups by the operation timing. Group I patients underwent cholecystectomy within 10 days after percutaneous cholecystostomy (n=30) and group II patients underwent cholecystectomy at more than 10 days after percutaneous cholecystostomy (n=44).

Results

There was no significant difference between groups in conversion rate to open surgery, operation time, perioperative complications rate, and days of hospital stay after operation. However, complications related to cholecystostomy such as catheter dislodgement occurred significantly more often in group II than group I (group I:group II=0%:18.2%; p=0.013).

Conclusions

Timing of laparoscopic cholecystectomy after percutaneous cholecystostomy did not influence postoperative outcomes. However, late surgery caused more complications related to cholecystostomy than early surgery. Therefore, early laparoscopic cholecystectomy should be considered over late surgery after percutaneous cholecystostomy insertion.

References

1. Mouret P. From the first laparoscopic cholecystectomy to the frontiers of laparoscopic surgery: the future prospectives. Dig Surg. 1991; 8:124–125.
crossref
2. Yamashita Y, Takada T, Hirata K. A survey of the timing and approach to the surgical management of patients with acute cholecystitis in Japanese hospitals. J Hepatobiliary Pancreat Surg. 2006; 13:409–415.
crossref
3. Zucker KA, Flowers JL, Bailey RW, Graham SM, Buell J, Imbembo AL. Laparoscopic management of acute cholecystitis. Am J Surg. 1993; 165:508–514.
crossref
4. Knight JS, Mercer SJ, Somers SS, Walters AM, Sadek SA, Toh SK. Timing of urgent laparoscopic cholecystectomy does not influence conversion rate. Br J Surg. 2004; 91:601–604.
crossref
5. Houghton PW, Jenkinson LR, Donaldson LA. Cholecystectomy in the elderly: a prospective study. Br J Surg. 1985; 72:220–222.
crossref
6. Radder RW. Ultrasonically guided percutaneous catheter drainage for gallbladder empyema. Diagn Imaging. 1980; 49:330–333.
7. Vogelzang RL, Nemcek AA Jr. Percutaneous cholecystostomy: diagnostic and therapeutic efficacy. Radiology. 1988; 168:29–34.
crossref
8. Hultman CS, Herbst CA, McCall JM, Mauro MA. The efficacy of percutaneous cholecystostomy in critically ill patients. Am Surg. 1996; 62:263–269.
9. Welschbillig-Meunier K, Pessaux P, Lebigot J, et al. Percutaneous cholecystostomy for high-risk patients with acute cholecystitis. Surg Endosc. 2005; 19:1256–1259.
crossref
10. Byrne MF, Suhocki P, Mitchell RM, et al. Percutaneous cholecystostomy in patients with acute cholecystitis: experience of 45 patients at a US referral center. J Am Coll Surg. 2003; 197:206–211.
crossref
11. Okamoto K, Takada T, Strasberg SM, et al. Tokyo Guideline Revision Committee. TG13 management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013; 20:55–59.
12. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Early scheduled laparoscopic cholecystectomy following percutaneous transhepatic gallbladder drainage for patients with acute cholecystitis. Surg Endosc. 2002; 16:1704–1707.
crossref
13. Han IW, Jang JY, Kang MJ, Lee KB, Lee SE, Kim SW. Early versus delayed laparoscopic cholecystectomy after percutaneous transhepatic gallbladder drainage. J Hepatobiliary Pancreat Sci. 2012; 19:187–193.
crossref
14. Yokoe M, Takada T, Strasberg SM, et al. Tokyo Guidelines Revision Committee. TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2013; 20:35–46.
crossref
15. Tokyo Guidelines for the management of acute cholangitis and cholecystitis. Proceedings of a consensus meeting, April 2006, Tokyo, Japan. J Hepatobiliary Pancreat Surg. 2007; 14:1–121.
16. Yamashita Y, Takada T, Strasberg SM, et al. Tokyo Guideline Revision Committee. TG13 surgical management of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2013; 20:89–96.
17. Farooq T, Buchanan G, Manda V, Kennedy R, Ockrim J. Is early laparoscopic cholecystectomy safe after the "safe period"? J Laparoendosc Adv Surg Tech A. 2009; 19:471–474.
crossref
18. Huber DF, Martin EW Jr, Cooperman M. Cholecystectomy in elderly patients. Am J Surg. 1983; 146:719–722.
crossref
19. Majeski J. Laparoscopic cholecystectomy in geriatric patients. Am J Surg. 2004; 187:747–750.
crossref
20. Kiviniemi H, Mäkelä JT, Autio R, et al. Percutaneous cholecystostomy in acute cholecystitis in high-risk patients: an analysis of 69 patients. Int Surg. 1998; 83:299–302.
21. Kim HO, Ho Son B, Yoo CH, Ho Shin J. Impact of delayed laparoscopic cholecystectomy after percutaneous transhepatic gallbladder drainage for patients with complicated acute cholecystitis. Surg Laparosc Endosc Percutan Tech. 2009; 19:20–24.
crossref

Table 1.
Clinical Characteristics
Characteristic Group I (n=30) Group II (n=44) p-value
Age (yr) 67.9±16.4 69.17±11.4 0.703
Sex (male:female) 17:13 27:17 0.686
WBC count on admission (/mm3) 14,696±5,207 14,090±465 0.670
Gallbladder stone 27 (90.0) 37 (84.1) 0.465
ASA score     0.825
 I 3 (10.0) 5 (11.4)  
 II 15 (50.0) 23 (52.3)  
 III 12 (40.0) 15 (34.1)  
 IV 0 (0) 1 (2.3)  
Comorbid disease     0.482
 None 5 (16.7) 4 (9.1)  
 Hypertension 18 (60.0) 23 (52.3)  
 Diabetes mellitus 10 (33.3) 8 (18.2)  
 Congestive heart failure 1 (3.3) 2 (4.5)  
 Ischemic heart disease 3 (10.0) 6 (13.6)  
 Malignant disease 4 (13.3) 4 (9.1)  
 Liver cirrhosis 1 (3.3) 0 (0)  
 Others 7 (23.3) 9 (20.5)  
Taking anticoagulants 22 (73.3) 28 (63.6) 0.454
Severity criteria a     0.949
 Mild 18 (60.0) 27 (61.4)  
 Moderate 11 (36.7) 15 (34.1)  
 Severe 1 (3.3) 2 (4.5)  

Values are presented as mean±SD or n (%).

Group I, patients underwent cholecystectomy within 10 days after percutaneous cholecystostomy insertion; group II, patients underwent cholecystectomy at more than 10 days after percutaneous cholecystostomy insertion.

WBC, white blood cell; ASA, American Society of Anesthesiologist.

a Updated Tokyo Guidelines for the Management of Acute Cholangitis and Cholecystitis (TG13) severity grading for acute cholecystitis.

Table 2.
Complications Associated with Percutaneous Cholecystostomy
Group I (n=30) Group II (n=44) p-value
0 (0%) 8 (18.2%) 0.013
  Tube obstruction, 1
Bleeding, 1
Bile leakage, 1
Tube dislodgement, 5
 

Group I, patients underwent cholecystectomy within 10 days after percutaneous cholecystostomy insertion; group II, patients underwent cholecystectomy at more than 10 days after percutaneous cholecystostomy insertion.

Table 3.
Postoperative Outcomes
  Group I (n=30) Group II (n=44) p-value
Operation time (min) 102.6±49.0 94.9±39.9 0.459
Hospital stay after operation (day) 7.4±5.3 7.6±6.8 0.910
Open conversion 10 (33.3) 11 (25.0) 0.435
 Severe inflammation 8 10  
 Severe bleeding 3 2  
 Bile duct injury 1 0  
Postoperative complications a 2 (6.7) 6 (13.6) 0.343
 Grade I 1 0  
 Grade II 0 2  
 Grade III 1 4  

Values are presented as mean±SD or n (%).

Group I, patients underwent cholecystectomy within 10 days after percutaneous cholecystostomy insertion; group II, patients underwent cholecystectomy at more than 10 days after percutaneous cholecystostomy insertion.

a Clavien-Dindo classification of surgical complications.

TOOLS
Similar articles